Literature DB >> 15996413

Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers.

Paolo Zamboni1, Gianluigi Scapoli, Vincenzo Lanzara, Marcello Izzo, Patrizia Fortini, Rea Legnaro, Annunziata Palazzo, Silvia Tognazzo, Donato Gemmati.   

Abstract

BACKGROUND: Severe chronic venous disease (CVD) is characterized by both dermal hemosiderin accumulation and matrix metalloproteinase (MMP) hyperactivation. The iron-driven pathway is one of the recognized mechanisms of MMP hyperactivation.
OBJECTIVE: To investigate the potential consequences of leg hemosiderin deposits on both iron metabolism and activation of MMPs.
METHODS: We contemporaneously assessed the following in the serum of the arm and ankle veins of 30 patients (C4-6) with CVD and 14 normal subjects: ferritin, transferrin, iron, percentage of transferrin iron binding capacity (%TIBC), and MMP-9. Optical microscopy examinations with Perls' staining of chronic wounds were also performed.
RESULTS: Histology consistently revealed iron deposits. Serum ferritin, iron, and %TIBC were significantly increased in the legs affected by severe CVD compared with the arm of the same subjects or the controls. In addition, iron and %TIBC were significantly elevated in the legs of ulcer patients. The rate of activation of MMP-9 was significantly elevated in CVD.
CONCLUSIONS: The increased iron deposition in legs affected by CVD seems to be more instable in ulcer patients, leading to iron release in the serum of the affected leg. Our data suggest the iron-driven pathway as a further mechanism for MMP hyperexpression leading to tissue lesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996413     DOI: 10.1111/j.1524-4725.2005.31611

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  15 in total

1.  Acute venous occlusion enhances matrix metalloprotease activity: Implications on endothelial dysfunction.

Authors:  Tom Alsaigh; Elizabeth S Pocock; John J Bergan; Geert W Schmid-Schönbein
Journal:  Microvasc Res       Date:  2010-10-16       Impact factor: 3.514

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

3.  HFE p.C282Y gene variant is associated with varicose veins in Russian population.

Authors:  Ekaterina A Sokolova; Alexandra S Shadrina; Kseniya S Sevost'ianova; Andrey I Shevela; Evgenii Yu Soldatsky; Evgenii I Seliverstov; Marina Yu Demekhova; Oleg A Shonov; Evgenii A Ilyukhin; Mariya A Smetanina; Elena N Voronina; Igor A Zolotukhin; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

Review 4.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

6.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

Review 7.  An overview of the relationship between anaemia, iron, and venous leg ulcers.

Authors:  Amy E Ferris; Keith G Harding
Journal:  Int Wound J       Date:  2019-08-16       Impact factor: 3.315

8.  Serum iron concentration and plasma oxidant-antioxidant balance in patients with chronic venous insufficency.

Authors:  Magdalena Budzyń; Maria Iskra; Zbigniew Krasiński; Łukasz Dzieciuchowicz; Magdalena Kasprzak; Bogna Gryszczyńska
Journal:  Med Sci Monit       Date:  2011-12

Review 9.  The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis.

Authors:  Paolo Zamboni
Journal:  J R Soc Med       Date:  2006-11       Impact factor: 18.000

10.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.